0002076369-26-000002.txt : 20261002 0002076369-26-000002.hdr.sgml : 20261002 20261002170437 ACCESSION NUMBER: 0002076369-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261002 DATE AS OF CHANGE: 20261002 EFFECTIVENESS DATE: 20261002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSIpharma, Inc. CENTRAL INDEX KEY: 0002076369 ORGANIZATION NAME: EIN: 392901038 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-551710 FILM NUMBER: 261437701 BUSINESS ADDRESS: STREET 1: 251 LITTLE FALLS DRIVE CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 866-403-5272 MAIL ADDRESS: STREET 1: 999 THIRD AVENUE STREET 2: SUITE 3900 CITY: SEATTLE STATE: WA ZIP: 98104-4076 D/A 1 primary_doc.xml X0708 D/A LIVE 0002076369 DSIpharma, Inc. 251 LITTLE FALLS DRIVE WILMINGTON DE DELAWARE 19808 866-403-5272 DELAWARE None None Corporation true 2025 Mark Ridall 251 Little Falls Drive Wilmington DE DELAWARE 19808 Executive Officer Director Kysha Ayana Pierre-Louis 251 Little Falls Drive Wilmington DE DELAWARE 19808 Executive Officer Director Other Health Care Decline to Disclose 06b true 0002076369-25-000001 2025-06-17 true true false 0 3000000 951250 2048750 false 18 0 0 90000 true false DSIpharma, Inc. KYSHA PIERRE-LOUIS Kysha Pierre-Louis President & Chief Financial Officer 2026-10-02